Search results
Everything you need to know about semaglutide weight loss drugs
New Scientist· 1 day agoOzempic and Wegovy are brand names for the drug semaglutide. Many countries have approved Wegovy for...
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Investor's Business Daily· 7 hours agoSemaglutide recipients were also 2.6 times and...Mounjaro's ability to improve morbidity and...
Mizuho still recommends Terns Pharma as a cheap entry to the weight-loss-drug craze
Market Watch· 6 hours agoJoshi. is currently conducting a Phase 1 trial of its TERN-601 small-molecule GLP-1 receptor...
Why Lilly And Novo Nordisk Will Keep Dominating The Market For Blockbuster GLP-1 Drugs
Forbes· 17 hours agoA survey released by KFF this week found that one in eight adults said they’ve taken a GLP-1 drug,...
What Is Ozempic Face and How Can You Avoid It?
Mercola· 6 days agoPrescriptions for weight loss medications have skyrocketed in recent years. The popularity of GLP-1 agonist drugs for weight management has boomed in recent years, and it shows — quite literally ...
How Common Are GLP-1 Drugs Like Ozempic? 13% of U.S. Adults Have Used Them
Healthline via AOL· 2 days agoA new poll found that one in eight American adults had used a GLP-1 drug, with half of those people...
A pill could solve the Zepbound and Wegovy shortage, Eli Lilly executive says
Quartz· 13 hours agoIt may take a weight loss pill for Eli Lilly to finally meet demand for its popular anti-obesity...
Wegovy may reduce need for diuretics for heart failure patients
UPI· 2 days agoResearch suggests that taking the blockbuster weight loss drug Wegovy (semaglutide) can help heart...
Fact Check Team: Study finds majority of Americans at risk of a heart condition
FOX 11 Green Bay· 1 day agoA new study published in the Journal of the American Medical Association found that a majority of...
Competing for cash may spur men to lose weight - UPI.com
UPI· 6 hours agoWeight loss was more successful among men who engaged in a competitive game versus those who weren't...